The following technical methods illustrate practical implementation approaches relevant to cardiac NAM applications, including organoid culture, engineered tissues, and 3D cardiac microenvironments compatible with disease modelling and drug screening. A cardiac NAM platform is only as valuable as its methodological robustness. Key evaluation dimensions include reproducibility, multicellular fidelity, mechanistic resolution, and translational interpretability.
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
Video & Protocol: https://www.jove.com/v/62539/developing-3d-organized-human-cardiac-tissue-within-microfluidic?utm_source=chatgpt.com DOI: 10.3791/62539-v
Implementation Domain:
Microenvironment control and anisotropic tissue organization
Relevance to Cardiac NAM:
Demonstrates structured 3D tissue assembly within a perfusable microfluidic environment. Highlights spatial organization, multicellular integration, and compatibility with functional assays relevant to safety and disease modeling.
Technical Features:
• Controlled perfusion
• Defined cell composition
• Functional assay compatibility
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Video & Protocol: https://www.jove.com/t/63097/generating-self-assembling-human-heart-organoids-derived-from?utm_source=chatgpt.com DOI: 10.3791/63097
Implementation Domain:
Developmentally inspired self-organization
Relevance to Cardiac NAM:
Illustrates directed differentiation strategies enabling formation of multicellular cardiac organoids with intrinsic structural patterning and spontaneous contractility.
Technical Features:
• Sequential WNT modulation
• Multilineage differentiation
• Functional imaging of beating tissue
Fabrication of 3D Arrays Using Human iPSC-Derived Cardiomyocytes, Fibroblasts, and Endothelial Cells
Video & Protocol: https://www.jove.com/t/61879/fabrication-3d-cardiac-microtissue-arrays-using-human-ipsc-derived?utm_source=chatgpt.com DOI: 10.3791/61879
Implementation Domain:
Structured multicellular assembly
Relevance to Cardiac NAM:
Demonstrates controlled incorporation of cardiomyocytes with stromal and endothelial components, enabling evaluation of cell-cell interactions and tissue-level functional readouts.
Technical Features:
• Defined cell ratios
• Scaffold-supported organization
• Contractility assessment
Cardiac NAM implementation strategies vary across architectural complexity, functional emphasis, and translational scope. Selection of an appropriate approach should align with defined context of use, desired mechanistic resolution, and regulatory integration objectives.
CardiacNAM.com provides structured, publicly referenced information on evaluation frameworks, regulatory integration, and translational considerations for cardiac New Approach Methodologies (NAMs). The content is intended to support informed discussion among regulators, translational scientists, and drug development teams.
Copyright © 2026 Cardiac NAM - All Rights Reserved